2[2]Downard CD,Betit P,Chang RW,et al.Impact of AMICAB on hemorrhagic complications of ECMO:a ten-year review[J].J Pediatr Surg,2003,38(8):1212-1216. 被引量：1
3[3]Dominguez TE,Mitchell M,Friess SH,et al.Use of recombinant factor VIla for refractory hemorrhage during extracorporeal membrane oxygenation[J].Pediatr Crit Care Med,2005,6(3):348-351. 被引量：1
4[4]Mejak B,Giacomuzzi C,Heller E,et al.Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia[J].J Extra Corpor Technol,2004,36(2):178-181. 被引量：1
5[5]Dager WE,Gosselin RC,Yoshikawa R,et al.Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation[J].Ann Pharmacother,2004,38(4):598-601. 被引量：1
6[6]Khoshbin E,Machin D,Killer H,et al..A potential propensity for failure secondary to clot embolism in neonatal ECMO[J].Perfusion,2005,20(3):177-181. 被引量：1
7[7]O'Neill JM,Schutze GE,Heulitt MJ,et al.Nosocomial infections during extracorporeal membrane oxygenation[J].Intensive Care Med,2001,27(8):1247-1253. 被引量：1
9[9]Montgomery VL,Strotman JM,Boss MP.lmpact of multiple organ system dysfunction and nosocomiai infactions on survival of children treated with extracorporeal membrsne oxygenation after heart surgery[J].Crit Care Med,2000,28(2):526-531. 被引量：1
10[10]Mangano CM,Diamondstone LS,Ramsay JG,et al.Renal dysfunction after myocardial revascuhrization:risk factors,adverse outcomes,and hospital resource utilization.The Multicenter Study of Perioperative Iachemia Research Group[J].Ann Intern Med,1998,128(3):194-203. 被引量：1
